These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 9570427)

  • 21. Comparative pharmacological properties among calcium channel blockers: T-channel versus L-channel blockade.
    Noll G; Lüscher TF
    Cardiology; 1998; 89 Suppl 1():10-5. PubMed ID: 9570424
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mibefradil, a pharmacologically distinct calcium antagonist.
    Ernst ME; Kelly MW
    Pharmacotherapy; 1998; 18(3):463-85. PubMed ID: 9620098
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of the calcium channel blockers, diltiazem and Ro 40-5967, on systemic haemodynamics and plasma noradrenaline levels in conscious dogs with pacing-induced heart failure.
    Su J; Renaud N; Carayon A; Crozatier B; Hittinger L
    Br J Pharmacol; 1994 Oct; 113(2):395-402. PubMed ID: 7834190
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of the novel T-type calcium channel antagonist mibefradil on human myocardial contractility in comparison with nifedipine and verapamil.
    Cremers B; Flesch M; Südkamp M; Böhm M
    J Cardiovasc Pharmacol; 1997 May; 29(5):692-6. PubMed ID: 9213214
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of ACE inhibition and angiotensin II type 1 receptor blockade on cardiac function and G proteins in rats with chronic heart failure.
    Yoshida H; Takahashi M; Tanonaka K; Maki T; Nasa Y; Takeo S
    Br J Pharmacol; 2001 Sep; 134(1):150-60. PubMed ID: 11522607
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of endogenous endothelin in chronic heart failure: effect of long-term treatment with an endothelin antagonist on survival, hemodynamics, and cardiac remodeling.
    Mulder P; Richard V; Derumeaux G; Hogie M; Henry JP; Lallemand F; Compagnon P; Macé B; Comoy E; Letac B; Thuillez C
    Circulation; 1997 Sep; 96(6):1976-82. PubMed ID: 9323089
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effects of mibefradil, a novel calcium channel antagonist on ventricular arrhythmias induced by myocardial ischemia and programmed electrical stimulation.
    Billman GE; Hamlin RL
    J Pharmacol Exp Ther; 1996 Jun; 277(3):1517-26. PubMed ID: 8667218
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Unique cardioprotective action of the new calcium antagonist mibefradil.
    Schulz R; Post H; Jalowy A; Backenköhler U; Dörge H; Vahlhaus C; Heusch G
    Circulation; 1999 Jan; 99(2):305-11. PubMed ID: 9892599
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human vascular to cardiac tissue selectivity of L- and T-type calcium channel antagonists.
    Sarsero D; Fujiwara T; Molenaar P; Angus JA
    Br J Pharmacol; 1998 Sep; 125(1):109-19. PubMed ID: 9776350
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discovery and main pharmacological properties of mibefradil (Ro 40-5967), the first selective T-type calcium channel blocker.
    Clozel JP; Ertel EA; Ertel SI
    J Hypertens Suppl; 1997 Dec; 15(5):S17-25. PubMed ID: 9481612
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inadequate ischaemia-selectivity limits the antiarrhythmic efficacy of mibefradil during regional ischaemia and reperfusion in the rat isolated perfused heart.
    Farkas A; Qureshi A; Curtis MJ
    Br J Pharmacol; 1999 Sep; 128(1):41-50. PubMed ID: 10498833
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Respective role of humoral factors and blood pressure in cardiac remodeling of DOCA hypertensive rats.
    Karam H; Heudes D; Hess P; Gonzales MF; Löffler BM; Clozel M; Clozel JP
    Cardiovasc Res; 1996 Feb; 31(2):287-95. PubMed ID: 8730406
    [TBL] [Abstract][Full Text] [Related]  

  • 33. T-type and L-type calcium channel blockers exert opposite effects on renin secretion and renin gene expression in conscious rats.
    Wagner C; Krämer BK; Hinder M; Kieninger M; Kurtz A
    Br J Pharmacol; 1998 Jun; 124(3):579-85. PubMed ID: 9647484
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hemodynamic and cardiac effects of the selective T-type and L-type calcium channel blocking agent mibefradil in patients with varying degrees of left ventricular systolic dysfunction.
    Rousseau MF; Hayashida W; van Eyll C; Hess OM; Benedict CR; Ahn S; Chapelle F; Kobrin I; Pouleur H
    J Am Coll Cardiol; 1996 Oct; 28(4):972-9. PubMed ID: 8837576
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Calcium blockade versus ACE inhibition in clipped and unclipped kidneys of 2K-1C rats.
    Véniant M; Heudes D; Clozel JP; Bruneval P; Ménard J
    Kidney Int; 1994 Aug; 46(2):421-9. PubMed ID: 7967354
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Respective role of humoral factors and blood pressure in aortic remodeling of DOCA hypertensive rats.
    Karam H; Heudes D; Gonzales MF; Löffler BM; Clozel M; Clozel JP
    Am J Hypertens; 1996 Oct; 9(10 Pt 1):991-8. PubMed ID: 8896651
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term heart rate reduction induced by the selective I(f) current inhibitor ivabradine improves left ventricular function and intrinsic myocardial structure in congestive heart failure.
    Mulder P; Barbier S; Chagraoui A; Richard V; Henry JP; Lallemand F; Renet S; Lerebours G; Mahlberg-Gaudin F; Thuillez C
    Circulation; 2004 Apr; 109(13):1674-9. PubMed ID: 14981003
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combination treatment with a calcium channel blocker and an angiotensin blocker in a rat systolic heart failure model with hypertension.
    Namba M; Kim S; Zhan Y; Nakao T; Iwao H
    Hypertens Res; 2002 May; 25(3):461-6. PubMed ID: 12135327
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The structurally novel Ca2+ channel blocker Ro 40-5967, which binds to the [3H] desmethoxyverapamil receptor, is devoid of the negative inotropic effects of verapamil in normal and failing rat hearts.
    Clozel JP; Véniant M; Osterrieder W
    Cardiovasc Drugs Ther; 1990 Jun; 4(3):731-6. PubMed ID: 1963792
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effects of handgrip stress test on hemodynamic parameters before and after cilazapril treatment in patients with heart failure.
    Tavli T; Göçer H
    Anadolu Kardiyol Derg; 2003 Mar; 3(1):38-42. PubMed ID: 12626309
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.